Zenas BioPharma Inc
For the period ended Dec 31, 2024. Filed Mar 11, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 11, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, duly authorized.
Date: March 11, 2025
| | ZENAS BIOPHARMA, INC. | |
|---|---|---|
| | | |
| | By: | /s/ Leon O. Moulder, Jr. |
| | Name: | Leon O. Moulder, Jr. |
| | Title: | Chief Executive Officer |
| | | (Principal Executive Officer) |
| | | |
|---|---|---|
| | By: | /s/ Jennifer Fox |
| | Name: | Jennifer Fox |
| | Title: | Chief Business Officer and Chief Financial Officer |
| | | (Principal Financial and Accounting Officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| | | |||
| Signature | | Title | | Date |
|---|---|---|---|---|
| | | | | |
| /s/ Leon O. Moulder, Jr.Leon O. Moulder, Jr. | | Chief Executive Officer and Director(Principal Executive Officer) | | March 11, 2025 |
| | | | | |
| /s/ Jennifer FoxJennifer Fox | | Chief Business Officer and ChiefFinancial Officer(Principal Financial and Accounting Officer) | | March 11, 2025 |
| | | | | |
| /s/ Patricia AllenPatricia Allen | | Director | | March 11, 2025 |
| | | | | |
| /s/ James BoylanJames Boylan | | Director | | March 11, 2025 |
| | | | | |
| /s/ Patrick EnrightPatrick Enright | | Director | | March 11, 2025 |
| | | | | |
| /s/ Tomas KiselakTomas Kiselak | | Director | | March 11, 2025 |
| | | | | |
| /s/ Hongbo Lu, Ph.D.Hongbo Lu, Ph.D. | | Director | | March 11, 2025 |
| | | | | |
| /s/ Jake NumJake Nunn | | Director | | March 11, 2025 |
| | | | | |
| /s/ John Orloff, M.D.John Orloff, M.D. | | Director | | March 11, 2025 |
|---|---|---|---|---|
| | | | | |
| /s/ Ting XiaoTing Xiao | | Director | | March 11, 2025 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.